diphenyleneiodonium has been researched along with angiotensinogen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y; Li, C; Liu, J; Lu, L; Ni, J; Shao, D; Shen, Y; Wang, R; Wang, Z; Xue, H; Yu, C; Yuan, P; Zhang, W; Zhou, L | 1 |
| Khan, SR; Peck, AB; Shimizu, N; Sunil, J; Tsuji, H; Uemura, H; Wang, W; Yoshimura, K | 1 |
2 other study(ies) available for diphenyleneiodonium and angiotensinogen
| Article | Year |
|---|---|
H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation.
Topics: Acetophenones; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Blood Glucose; Cell Proliferation; Cells, Cultured; Collagen Type IV; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Diabetes Mellitus, Experimental; Glucose; Hydrogen Sulfide; Hyperglycemia; Kidney; Losartan; Mesangial Cells; NADPH Oxidases; Onium Compounds; Peptidyl-Dipeptidase A; Rats; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Transforming Growth Factor beta1 | 2013 |
Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Angiotensinogen; Animals; Calcium Oxalate; Cell Line; Cytochrome P-450 CYP11B2; Disease Models, Animal; Enzyme Inhibitors; Ethylene Glycol; Gene Expression Profiling; Hyperoxaluria; Male; Mineralocorticoid Receptor Antagonists; NADPH Oxidase 4; NADPH Oxidases; Onium Compounds; Protein Phosphatase 2; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Receptors, Mineralocorticoid; Renin; Renin-Angiotensin System; RNA, Messenger; Spironolactone; Steroid 11-beta-Hydroxylase | 2016 |